Please ensure Javascript is enabled for purposes of website accessibility

Why Sundial Growers, Hexo, and OrganiGram Stocks Jumped Today

By Howard Smith – Aug 23, 2021 at 2:41PM

Key Points

  • Canadian marijuana companies are seeing a rebound in sales after a pandemic-impacted slowdown.
  • One company's shareholders still aren't happy with the pricing of a new share offering.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cannabis stocks are rebounding today after two weeks of sharp declines.

What happened

There's been some good news in the Canadian cannabis sector recently, but it hasn't been reflected in several of the stocks. Shares of three Canadian growers are rebounding some today, however. The stocks of Hexo (HEXO 0.48%) and OrganiGram Holdings (OGI 3.00%) were up 9.3% and 7.3%, respectively, as of 2:05 p.m. EDT. Shares of Sundial Growers (SNDL 5.45%) didn't bounce quite as much, but were 4.1% higher than Friday's closing price at that same time. 

So what

Over the past two weeks, Sundial and OrganiGram shares are down 12.2% and 7.3%, respectively, even with today's jump. Investors hit Hexo even harder after it announced it would further dilute existing shareholders to raise new capital. Hexo shares are down more than 32% just since Aug. 9. Today, investors are shifting sentiment in these names, at least for the time being, as the cannabis companies are experiencing a recovery from closures and restrictions related to the pandemic. 

Hands handling marijuana flower buds.

Image source: Getty Images.

Now what

Sales are beginning to improve in Canada after impacts from the pandemic dented results over the past year. Canadian retail cannabis sales grew 58% to a record in June compared with one year ago, according to industry publication New Cannabis Ventures. Sundial Growers just reported its second-quarter results on Aug. 12, saying sales are improving with 8% sequential growth of its cannabis revenue compared with the first quarter. 

OrganiGram had an even more impressive sequential improvement, with gross sales soaring 51% above its prior quarter's figure. The company also just launched a new lozenge product. The new JOLTS ingestible uses a patent-pending formulation to deliver high-potency THC in a convenient form. 

Hexo has been trading less on fundamentals and more on its recent announcement to raise $140 million from a stock offering. But investors weren't happy with the terms of the capital raise, sending shares plummeting last week. 

For today, cannabis investors are following the generally positive market sentiment, giving these names a reprieve from recent declines. 

Howard Smith has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool recommends HEXO Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Nearly 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Sndl  Stock Quote
$2.71 (5.45%) $0.14
OrganiGram Stock Quote
$1.03 (3.00%) $0.03
HEXO Corp. Stock Quote
HEXO Corp.
$0.17 (0.48%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.